BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3148596)

  • 1. A case-control study of the effectiveness of cervical cancer screening in Osaka, Japan.
    Sobue T; Suzuki T; Hashimoto S; Yokoi N; Fujimoto I
    Jpn J Cancer Res; 1988 Dec; 79(12):1269-75. PubMed ID: 3148596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, Japan.
    Makino H; Sato S; Yajima A; Komatsu S; Fukao A
    Tohoku J Exp Med; 1995 Mar; 175(3):171-8. PubMed ID: 7792786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
    Makino H; Sato S; Yajima A; Fukao A
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening in Japan. A case-control study.
    Sato S; Makino H; Yajima A; Fukao A
    Acta Cytol; 1997; 41(4):1103-6. PubMed ID: 9250306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of screening for cervical cancer in Taiwan. A case-control study].
    Lai MY; Chou P
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Feb; 49(2):81-5. PubMed ID: 1315201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cervical screening and prevention of invasive cervical cancer in Ontario: a population-based case-control study.
    Vicus D; Sutradhar R; Lu Y; Kupets R; Paszat L;
    Int J Gynecol Cancer; 2015 Jan; 25(1):106-11. PubMed ID: 25377725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecological care of elderly women. Another look at Papanicolaou smear testing.
    Mandelblatt J; Gopaul I; Wistreich M
    JAMA; 1986 Jul; 256(3):367-71. PubMed ID: 3723723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between cervical cancer screening and mortality from cervical cancer: a population based case-control study.
    Vicus D; Sutradhar R; Lu Y; Elit L; Kupets R; Paszat L;
    Gynecol Oncol; 2014 May; 133(2):167-71. PubMed ID: 24589414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study.
    Landy R; Pesola F; Castañón A; Sasieni P
    Br J Cancer; 2016 Oct; 115(9):1140-1146. PubMed ID: 27632376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of screening in preventing cervical cancer among older women.
    Kamineni A; Weinmann S; Shy KK; Glass AG; Weiss NS
    Cancer Causes Control; 2013 Sep; 24(9):1653-60. PubMed ID: 23744043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papanicolaou smear screening and cervical cancer. What can you expect?
    Stenkvist B; Bergström R; Eklund G; Fox CH
    JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of cervical screening: a population-based case-control study.
    van der Graaf Y; Zielhuis GA; Peer PG; Vooijs PG
    J Clin Epidemiol; 1988; 41(1):21-6. PubMed ID: 3335869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cervical cancer in Latin America: a case-control study.
    Herrero R; Brinton LA; Reeves WC; Brenes MM; de Britton RC; Gaitan E; Tenorio F
    Int J Epidemiol; 1992 Dec; 21(6):1050-6. PubMed ID: 1336485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population.
    Guilcher SJ; Newman A; Jaglal SB
    J Womens Health (Larchmt); 2010 Jan; 19(1):57-63. PubMed ID: 20088659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papanicolaou smear screening interval and risk of cervical cancer.
    Shy K; Chu J; Mandelson M; Greer B; Figge D
    Obstet Gynecol; 1989 Dec; 74(6):838-43. PubMed ID: 2586947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
    Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
    Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.